Pay in 4 interest-free payments of $6.91 Learn more
Ships within 48 hours · Estimated delivery Aug 27 - Sep 1
Splitting doses disrupts steady-state concentrations and lacks clinical evidence for equivalent or improved outcomes
This concentration demands extreme precision
First approved for type 2 diabetes as Ozempic, the higher-dose Wegovy is intended for chronic weight management, delivering semaglutide at 15-20% of the body weight. It acts on GLP-1 receptors in the pancreas, promoting insulin secretion and reducing glucagon, which regulates blood sugar
One version incorporates a "drug affinity complex" (DAC) that binds to blood albumin and extends the peptide's activity for days, while a separate non-DAC version (also sold as "Mod GRF 1-29") clears the body much faster and produces shorter, more pulsatile GH spikes
US$ 26.86
US$ 28.34
US$ 29.02
US$ 24.64
US$ 28.08
US$ 24.58
US$ 26.54
